1994
DOI: 10.1152/ajpheart.1994.266.6.h2256
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of responses to bradykinin in the pulmonary vascular bed of the cat

Abstract: Responses to bradykinin (BK) were investigated in the pulmonary vascular bed of the cat under conditions of controlled pulmonary blood flow and constant left atrial pressure when lobar arterial pressure was elevated to a high steady level. Under elevated-tone conditions, BK caused dose-related decreases in lobar arterial pressure. After administration of Hoe-140, a BK B2-receptor antagonist, vasodilator responses to BK were reduced in a selective manner. Vasodilator responses to BK were unchanged by atropine, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0

Year Published

1994
1994
2016
2016

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 0 publications
2
12
0
Order By: Relevance
“…These results show the hindlimb vasodilator responses to PN, and to the NO donors, sodium nitroprusside and DEA/NO, were enhanced in duration at a time when vasodilator responses to the beta 2 receptor agonist, albuterol, were not altered. These data along with the observation that the type 4 cAMP phosphodiesterase inhibitor, rolipram, did not alter the duration of the response to PN, provides evidence in support of the hypothesis that PN induced vasodilation in the cat circulation is mediated, at least, in part by a cGMP-dependent mechanism [222,223]. Although experiments with zaprinast provide evidence in support of a cGMP dependent mechanism, additional support for this mechanism could be derived from experiments with inhibitors of guanylate cyclase and of cGMP dependent protein kinase.…”
Section: Vasorelaxant Properties Of Peroxyni-tritesupporting
confidence: 62%
“…These results show the hindlimb vasodilator responses to PN, and to the NO donors, sodium nitroprusside and DEA/NO, were enhanced in duration at a time when vasodilator responses to the beta 2 receptor agonist, albuterol, were not altered. These data along with the observation that the type 4 cAMP phosphodiesterase inhibitor, rolipram, did not alter the duration of the response to PN, provides evidence in support of the hypothesis that PN induced vasodilation in the cat circulation is mediated, at least, in part by a cGMP-dependent mechanism [222,223]. Although experiments with zaprinast provide evidence in support of a cGMP dependent mechanism, additional support for this mechanism could be derived from experiments with inhibitors of guanylate cyclase and of cGMP dependent protein kinase.…”
Section: Vasorelaxant Properties Of Peroxyni-tritesupporting
confidence: 62%
“…The results of the present studies suggest, however, that kinin B1 and B2 receptors mediating the release of nitric oxide are present on endothelial cells in the pulmonary vascular bed of the cat. 34,35,37 Although the present data suggest that DABK increases lobar arterial pressure by releasing catecholamines in the lung and activating a-adrenergic receptors under low-tone conditions but decreases lobar arterial pressure by releasing nitric oxide under elevated-tone conditions, the exact mechanism by which the increase in tone changes the direction and mechanism of the response is uncertain. Since both pressor and depressor responses are reduced by des-Arg9,[Leu8]-BK, they are mediated by activation of kinin Bi receptors.…”
Section: Responses To Dabk Under Elevated-tone Conditionsmentioning
confidence: 72%
“…Zaprinast inhibits the degradation of cGMP in the vascular smooth muscle by inhibiting cGMP phosphodiesterase activity and thus increases the cellular level of cGMP, which has been shown to augment vasorelaxation to guanylyl cyclase activation in other blood vessels. 36,37 In the pilot studies, a high concentration of zaprinast (10 M) produced 10% to 15% vasodilation (n ϭ 4). To avoid the confounding effect of reducing vascular tone on lactate-induced vasodilation, we chose a lower concentration of zaprinast (1 M) for the present study.…”
Section: Discussionmentioning
confidence: 97%